Lead encephalopathy in the developing rat: effect upon myelination.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism / Q000473:pathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D002554:Cerebrosides / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D007855:Lead Poisoning / Q000378:metabolism / Q000473:pathology*; D008854:Microscopy, Electron; D009186:Myelin Sheath / Q000187:drug effects*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D013109:Sphingomyelins / Q000378:metabolism; D013433:Sulfoglycosphingolipids / Q000378:metabolism
D002554:Cerebrosides; D009419:Nerve Tissue Proteins; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D013109:Sphingomyelins; D013433:Sulfoglycosphingolipids; D004247:DNA; D002784:Cholesterol